Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
04/06/2020 - 4 minutes
News and Trends
What Did European Oncology Players Offer at ASCO 2020?
Despite widespread clinical trial delays caused by the coronavirus pandemic, many oncology biotechs have been…
03/06/2020 - 10 minutes
AI Drug Discovery Firm Exscientia Closes €54M Series C
UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its…
29/05/2020 - 3 minutes
Argenx Follows up Phase III Success with Giant €785M Global Offering
The Dutch biotech argenx has cashed in on recent positive phase III results by launching…
29/05/2020 - 2 minutes
Spanish Neurology Biotech Launches with €7.6M Series A
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
29/05/2020 - 3 minutes
French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring…
28/05/2020 - 2 minutes
MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience
The US-based big pharma MSD has entered the race to be the first to develop…
28/05/2020 - 3 minutes
‘Just Add Water’ GM Mosquitoes Suppress Wild Population by 95%
Water-soluble capsules containing the eggs of genetically modified mosquitoes developed by the UK company Oxitec…
27/05/2020 - 4 minutes
Argenx’s Rare Disease Treatment Strikes Gold in Phase III
The Dutch biotech argenx aims to apply for FDA approval of its lead candidate efgartigimod…
26/05/2020 - 3 minutes
Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products
The German companies Evonik and Beiersdorf will work together on a joint research project to…
25/05/2020 - 2 minutes
Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease
An initially promising drug has failed to show benefits in a phase II trial for…
22/05/2020 - 2 minutes
Phase II Success for Once-a-Day Eye Drops after Cataract Surgery
A nanoparticle steroid therapy developed by Swiss biotech Oculis has reduced eye pain and inflammation…
20/05/2020 - 3 minutes
